Research Funded To Date

CIRCULATING BIOMARKERS THAT PREDICT RESPONSE TO AN IRREVERSIBLE PAN-HER KINASE INHIBITOR IN EGFR-AMPLIFIED GBM.

PI: Andrew S. Chi, M.D., Ph.D.
Divisions of Hematology/Oncology and Neuro-Oncology
Department of Neurology
Massachusetts General Hospital & Harvard Medical School

Award: $150,000 for one year


TUMOR-SPECIFIC RADIATION SENSITIZATION IN GLIOBLASTOMA BY TARGETING THE P53-INDEPENDENT CHECKPOINT RESPONSE.

PI: Prakash Chinnaiyan, M.D.
Assistant Member, Department of Radiation Oncology and Experimental Therapeutics
H. Lee Moffitt Cancer Center and Research Institute

Award: $150,000 for one year


FEASIBILITY STUDY OF A PERSONALIZED AND ADAPTABLE CANCER VACCINE FOR PATIENTS WITH GLIOBLASTOMA.

PI: Duane A. Mitchell, M.D., Ph.D.
Assistant Professor of Neurosurgery
Associate Director, Duke Brain Tumor Immunotherapy Program
The Preston Robert Tisch Brain Tumor Center at Duke

Award: $150,000 for one year


PERSONALIZED IMMUNOTHERAPY FOR GLIOBLASTOMA: GENETIC SIGNATURES THAT MAY PREDICT RESPONSIVENESS.

PI: Robert M. Prins, Ph.D.
Assistant Professor of Neurosurgery
University of California Los Angeles (UCLA) School of Medicine

Award: $150,000 for one year